Bernstein upgraded AstraZeneca (NYSE: AZN) from Market Perform to Outperform with a price target of $39.00 (from $30.00).Analyst Tim Anderson ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE